Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS).


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
12 2021
Historique:
received: 13 06 2021
accepted: 08 09 2021
pubmed: 18 9 2021
medline: 4 1 2022
entrez: 17 9 2021
Statut: ppublish

Résumé

Lifestyle intervention (LI) can prevent type 2 diabetes, but response to LI varies depending on risk subphenotypes. We tested whether individuals with prediabetes with low risk (LR) benefit from conventional LI and individuals with high risk (HR) benefit from an intensification of LI in a multicenter randomized controlled intervention over 12 months with 2 years' follow-up. A total of 1,105 individuals with prediabetes based on American Diabetes Association glucose criteria were stratified into an HR or LR phenotype based on previously described thresholds of insulin secretion, insulin sensitivity, and liver fat content. LR individuals were randomly assigned to conventional LI according to the Diabetes Prevention Program (DPP) protocol or control (1:1) and HR individuals to conventional or intensified LI with doubling of required exercise (1:1). A total of 908 (82%) participants completed the study. In HR individuals, the difference between conventional and intensified LI in postchallenge glucose change was -0.29 mmol/L [95% CI -0.54; -0.04],

Identifiants

pubmed: 34531293
pii: db21-0526
doi: 10.2337/db21-0526
doi:

Substances chimiques

Blood Glucose 0

Banques de données

ClinicalTrials.gov
['NCT01947595']
figshare
['10.2337/figshare.16613905']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2785-2795

Informations de copyright

© 2021 by the American Diabetes Association.

Auteurs

Andreas Fritsche (A)

German Center for Diabetes Research (DZD), Neuherberg, Germany andreas.fritsche@med.uni-tuebingen.de.
Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Robert Wagner (R)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Martin Heni (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Kostantinos Kantartzis (K)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Jürgen Machann (J)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
Section on Experimental Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.

Fritz Schick (F)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Section on Experimental Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.

Rainer Lehmann (R)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Tübingen, Germany.

Andreas Peter (A)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Tübingen, Germany.

Corinna Dannecker (C)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Louise Fritsche (L)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Vera Valenta (V)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Renate Schick (R)

German Center for Diabetes Research (DZD), Neuherberg, Germany.

Peter Paul Nawroth (PP)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg, Germany.
Institute for Diabetes and Cancer, IDC Helmholtz Center, Munich, Germany.
Joint Heidelberg-IDC Translational Diabetes Program, Neuherberg, Germany.

Stefan Kopf (S)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg, Germany.

Andreas F H Pfeiffer (AFH)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Stefan Kabisch (S)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Ulrike Dambeck (U)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Michael Stumvoll (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Medicine, Endocrinology and Nephrology, Universität Leipzig, Leipzig, Germany.

Matthias Blüher (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Medicine, Endocrinology and Nephrology, Universität Leipzig, Leipzig, Germany.

Andreas L Birkenfeld (AL)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany.

Peter Schwarz (P)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany.

Hans Hauner (H)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute of Nutritional Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Julia Clavel (J)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute of Nutritional Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Jochen Seißler (J)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Diabetes Research Group, Medical Department 4, Ludwig-Maximilians University Munich, Munich, Germany.

Andreas Lechner (A)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Diabetes Research Group, Medical Department 4, Ludwig-Maximilians University Munich, Munich, Germany.

Karsten Müssig (K)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Katharina Weber (K)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Michael Laxy (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute of Health Economics and Health Care Management, Neuherberg, Germany.

Stefan Bornstein (S)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany.

Annette Schürmann (A)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Michael Roden (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Martin Hrabe de Angelis (MH)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute of Experimental Genetics, IEG Helmholtz Center Munich, Neuherberg, Germany.
Chair of Experimental Genetics, School of Life Sciences Weihenstephan, Technical University of Munich, Munich, Germany.

Norbert Stefan (N)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Hans-Ulrich Häring (HU)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard-Karls University Tübingen, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH